Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates

Stock News

2025/12/02

Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. ("Sikon Biological"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. ("Zhengzhou Biaoyuan"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.

The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1164625297"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164625297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164625297?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164625297","market":"other","top_or_hot":-1,"title":"Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates","media":"Stock News","content":"<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Autobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAutobio Diagnostics (603658.SH) and Subsidiaries Obtain Medical Device Registration Certificates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-02 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.</p>\n<p>The acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1164625297","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164625297","pubTimestamp":1764668777,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","603658":"安图生物","BK1583":"高瓴概念","BK0239":"医药制造","09997":"康基医疗","BK1100":"医疗保健设备","BK1222":"医疗保健用品","09996":"沛嘉医疗-B","BK1574":"生物医药B类股","BK0046":"生物疫苗"},"translate_title":"奥特生物诊断（603658.SH）及子公司获得医疗器械注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"603658":1,"09996":1,"09997":1},"content_text":"Autobio Diagnostics Co., Ltd (603658.SH) announced that the company and its wholly-owned subsidiary, Zhengzhou Sikon Biological Engineering Co., Ltd. (\"Sikon Biological\"), as well as its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd. (\"Zhengzhou Biaoyuan\"), have recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.\nThe acquisition of these medical device registration certificates further enriches the company's product portfolio, continuously meeting market demand. These additions serve as an effective supplement to Autobio's existing diagnostic products and will gradually enhance the overall competitiveness of the company's offerings. However, the short-term impact on the company's financial performance is expected to be limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}